Clinical Trial Update: Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes [Phase 2]

View source ↗

Summary

NephroGenex completed a Phase 2 safety and efficacy study of Pyridorin in patients with diabetic nephropathy (nephropathy due to type 2 diabetes).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Pyridorin

Snippet

Sponsor: NephroGenex, Inc. | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED